$87.99
0.931.07%
Last update: Oct 28, 5:25 PM
BioNTech SE (BNTX) Stock Price, Quote, News & History
BNTXNASDAQ
BioNTech and DualityBio report modest Phase 3 breast cancer survival gains alongside higher lung toxicity, limiting overall patient benefit.
You can purchase shares of BioNTech (NASDAQ:BNTX) through any online brokerage.
Other companies in BioNTech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BioNTech has a consensus price target of $130.64.
The stock price for BioNTech (NASDAQ: BNTX) is $87.01 last updated October 28, 2026 at 5:25 PM EDT.
There are no upcoming dividends for BioNTech.
BioNTech does not have any upcoming earnings scheduled.
There is no upcoming split for BioNTech.
BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several...
